Sign in
WithdrawnPhase 1/2

CardiAQ-Edwards™ Transcatheter Mitral Valve Replacement (TMVR) Study

Key facts

Who runs it
Edwards Lifesciences
Where
Canada, Denmark, France, Germany, Italy, Netherlands, and Switzerland15 sites in 7 countriesChoose a country to see its sites
Trial code
Status
Withdrawn
Phase
Phase 1/2
Started
Nov 2016
Ended
Oct 2024
Type of study
Interventional
Treatments tested
  • Transcatheter Mitral Valve Re-placement (TMVR) with the CardiAQ-Edwards™ Transcatheter Mitral Valve
Record updated
9 January 2018

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • NYHA ≥ II
  • Moderate/severe or severe mitral regurgitation
  • Prohibitive risk for open-heart surgery
  • Meets anatomical criteria

Who cannot take part

  • Need for emergent or urgent surgery
  • Prior mechanical aortic valve replacement
  • Any prior surgical or transcatheter repair (excluding balloon valvuloplasty) or replacement of the mitral valve
  • Clinically significant, untreated coronary artery disease
  • Active infection
  • Unsuitable anatomy
  • Preexisting device in the left ventricular apex
  • Limited life expectancy (< 12 months)

This trial has no sites in United States.

It has sites in 7 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Clinical study to evaluate the safety and performance of the CardiAQ-Edwards™ Transcatheter Mitral Valve

The group in the trial

  • TreatmentTreatment being tested

    Treatment with the CardiAQ-Edwards™ Transcatheter Mitral Valve (transapical or transseptal delivery)

    Treatment: Transcatheter Mitral Valve Re-placement (TMVR) with the CardiAQ-Edwards™ Transcatheter Mitral Valve

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Record updated
9 January 2018